MTOR and cancer: To date, there are no data on inositol use in patients affected by neuroendocrine cells, but studies on other cancer cells have suggested a role of IP6 in the induction of cell apoptosis by inhibiting the Akt/mTOR pathway and PI3k pathways, supporting the rationale for the use of inositols in combination with everolimus in NENs.